Haemorrhagic fever / Ebola outbreaks have been reported - accident, natural or bio-weapon?

[Meggings]

Excuse me ....

[avid]

bad scenarios - total grieving

[Matisse]

The four patients admited to the hospital yesterday in Madrid suspected of having ebola have so far all tested negative. The man from Nigeria on the air france flight seems to have malaria. Also all of the patients in quarentine who had contact with the infected nurse Teresa Romero all test negative for the moment. Just thought I would throw in some good news....

[Bob]

Summary from previous page -

• CDC says sorry.. Texas hospital corporation says sorry for the misdiagnosis
  
• Nurses say they know they were mismanaged, and followed their supervisors instructions but got sick
  
• Belize and Mexico turn away a cruise ship with a problem, refusing to let a passenger or two disembark
  
• Nurses moved out of Texas hospital
  
• New CZAR put into place, no medical experience but a great political interface - medical people disenchanted by the choice
  
• CDC documents sent to hospitals don't talk about ebola control, but a lower virus, RSV - inadequate protection practices (worldwide) therefore apparently is promulgated by the agency
  
• Various schools and businesses considering and doing voluntary control measures
  
• Questions about PSYOPS being conducted..

As emphasised in the OP, the first post, the purpose of this thread is not to try to debunk ebola activity - the virus exists and mis-information has been put out by agencies.. Liberia has instituted a forced clamp-down on news from reporters in Liberia.

Sierra Leone is under-reporting cases, and deaths (I know that from first hand discussion with a trusted contact in Nigeria who is in contact with networks in the region from Cameroon, Nigeria, Coast de Ivorie, Liberia, Guinea, Sierra Leone, the Gambia, Senegal, and Morocco.) The contact is confirming the ebola infection exists as well as NUMEROUS other infections and diseases that are harming the People because hospitals are now either shutting down or are overwhelmed unable to take (house in a room) in ANYONE with any other disease, IN THE HOTZONE countries.. Sepsis is reported as being very present. Anyone that can see a doctor is ushered out by a nurse fast back into the community. The contact has said, misinformation and disinformation is spreading because of POLITICAL REASONS - anything that will slam a politician, can put $$ or "status" in the opposing party's coffers, or in the minimum influence public perception of the politicians (those with the political axe to grind); and those people are using Ebola as a political weapon - that IS what is happening. They use whatever tool will get them the most attention.

There are plenty of threads on the Forum that one can take the conspiracy theory. I would like to concentrate on WHERE WHEN WHY and by WHOM and what accepted medical treatment are being used, or will be or what anti-viral medical treatments are being suppressed. There are plenty of alternative TREATMENT threads on the FORUM and this thread is not for those discussions.

Where suspected alerts or alarms are very important for people to know, to be alert, wake up and find out what is happening in their space. Who is involved is important to know.

A whistle blowers report such as from a NURSE or DOCTOR expressing what is happening, what is being suppressed as to WHERE an outbreak could happen if unchecked, could provide good data for this thread and thereby help people stay informed.

A document that says some country, or agency or group has developed a bioweapon and deployed it matches the subject of this thread - Is the outbreak NATURAL, or ACCIDENTAL (such as poor equipment, or poor training, or deliberate mis-training)... that information is useful for instance.. A bioweapon report and who is conducting such tests, who are conductiing countermeasure studies is useful.. Historically what countermeasures stop the hemorrhagic fever viruses.

A brief mention on the live virus vaccine treatment I think is valid for specifically the hemorrhagic fever virus.. Discussing flu virus vaccines, or mercury in vaccines, adjunctives is not appropriate for this thread, there are plenty of other threads dealing with vaccines..

*Hotzone countries - Liberia, Guinea, Sierra Leone.

Thanks

-----------------------------

[Bob]

Yikes - up to 1000 people now in the "circles" being in the checking loop.. All from one person's flight on a commercial plane (twice) when she should have known better, but she was CLEARED by the CDC that it was OK to fly - she wanted to get to the location of the wedding practice.. (the justifier)

As of Friday, a pool of about 1,000 people are being watched for symptoms, have been asked to monitor themselves or have been urged to check with a counselor at the Centers for Disease Control and Prevention. The group includes a handful of people who have been ordered into quarantine, a larger group that is being closely watched with temperatures taken at least daily and a much larger group of travelers who may haven flown on a Frontier Airlines jetliner used at some point by an Ebola patient traveling with a low-grade fever.

None of those being monitored, regardless of their group, has exhibited any Ebola symptoms.

Wrap one's head around the Carnival "trip"..

HOW many people now could possibly be told they are "in the circle" when the get off the boat? 21 days of monitoring? HOW will that be addressed, who will say it will be a $$$ burden on the ship owners, or the passengers? Some reports are saying over 4400 souls on that boat. Where did the lab supervisor and her husband travel on the ship? Thing which is a positive, the supervisor had been working with the samples 19 days ago say the reports.. And is quarantined on board.. That could be the lining for any dark clouds to be lifted soon by the time the ship gets back to home port in a couple days..

[Roisin]

Newest Ebola Headline 10:46 EST from Cleveland, Ohio

Nurse on flights may have had more advanced case of Ebola
The Hill - ‎44 minutes ago‎
The nurse who flew between Dallas and Cleveland and later tested positive for Ebola may have been at a more advanced stage of the disease than previously thought, the president of Frontier Airlines said.

Barry Biffle notified employees on Friday about the findings from the Centers for Disease Control and Prevention, the Associated Press reports.

The CDC has said those diagnosed with Ebola are more contagious as the disease advances, and when symptoms progress.
The CDC reassured the airline company that crew members on the flights are at low risk of exposure to the disease, Biffle said.

Frontier put the pilots and flight attendants on leave for 21 days, which health experts say is the maximum amount of days it could take someone exposed to Ebola to become sick.

All passengers on the flight with the nurse Amber Joy Vinson have been notified, Biffle said.
http://thehill.com/policy/healthcare...-case-of-ebola

[sheme]

There is a kind of slow motion inevitability about this announcement, you know the sort of scene they slow mo in the movies -just before the car crashes.

[sheme]

This might be of interest, Artificial spleen removes HIV Ebola and virus with magnetic nano beads, to be tested on pigs next.

http://www.ibtimes.co.uk/artificial-...agnets-1465585

[Bob]

About the VSV-EBOV – Canada’s Experimental vaccine for Ebola

Get ready, here it comes Africa -

Being sent to WHO in Geneva, the first shipment goes out Monday.

VSV-EBOV is an experimental Ebola vaccine developed by researchers at the Public Health Agency of Canada’s National Microbiology Laboratory (NML).

This vaccine is considered "experimental". It is based on an animal virus called vesicular stomatitis virus (VSV) that is combined with a portion of the protein covering of the Ebola virus. When administered, it induces an immune response against the Ebola virus.

The VSV acts as the infectious "core" that is used to allow the virus proteins to be injected into the cells. The antibody response then rapidly goes after the resultant human viral infection, creating antibodies (and a genetic tag to those viral proteins). In theory, the safety question is to determine the dose level - how many infectious particles can be safely tolerated..

Being tolerated means, because of die-off of the infected human cells, how many can be safely cleared from the body and how many anti-bodies can be created.. Is that 20,000,000,000 (thats 20 billion) virus particles or 50 billion for instance.

Testing for appropriate dose level is happening at the US Walter Reed Army medical facility in Maryland USA, (the facility's Institute of Research).

Live virus verses weakened virus.. One of the factors to be determined is how often will a booster shot be required. For instance Yellow Fever vaccination requires an initial dose where in about 10-15 days "immune system protection" capability starts, and lasts for up to 10 years before they say a booster vaccination is required to keep more viral particles in the body so that antibody production continues. (a constant low grade war exists with antibody production going after a continual low grade "yellow fever")..

Canadian Statement - that they are performing a humanitarian effort to make available the vaccine products - they are helping the WHO fulfill their role in Africa overcome the Ebola virus outbreak..

Canada's 'project' is NOT a "Bill Gates" virus vaccination campaign, but is instituted BY the CANADIAN GOVERNMENT. The other vaccine maker is based in BRITAIN, Glaxo-Smith-Kline. Gates has nothing to do with the EBOLA VACCINES being developed by CANADA. The US MILITARY ROLE is to obtain a vaccine for it's troops. USAMRIID and DTRA are two US government organizations who have contributed research and FUNDING for these other COUNTRIES.

(above from their website announcement at: http://www.phac-aspc.gc.ca/id-mi/vsv-ebov-fs-eng.php)

"The Government of Canada will be shipping 800 vials of its experimental Ebola vaccine to the World Health Organization (WHO) in Geneva, beginning with its first shipment on Monday, October 20, 2014. These shipments will fulfill the Government’s vaccine donation commitment to the ongoing Ebola outbreak in West Africa.

"The Public Health Agency of Canada is supplying the vaccine to the WHO in its role as the international coordinating body for the Ebola outbreak, so that the vaccine can be made available as an international resource. The WHO, in consultation with partners, including the health authorities from the affected countries, will guide and facilitate how the vaccine should be distributed and used.

"The remaining vials of the vaccine will be kept in Canada for further research and compassionate use as required."

-----------------------------------

VSV - understanding the nature of the viral engine that has been modified to contain Ebola proteins

Researchers expect different types of vaccines to have different effects on the immune system.

Because the vaccine being tested in Mali and Baltimore uses a weakened virus, it might be tolerated better but not last as long as vaccines that use live viruses, said Dr. Thomas Geisbert, a professor of microbiology and immunology at the University of Texas Medical Branch at Galveston who has studied Ebola for decades and helped develop the Profectus vaccine.

The trials are also testing the performance of varying dosage levels, ranging from 25 billion to 50 billion modified virus particles.

It is unclear whether some vaccine candidates could require rounds of booster shots to prolong immunity, or whether others might provide longer immunity but at greater risk of side effects.

Profectus' vaccine uses a live virus that has been genetically altered. It can still reproduce, but its ability to do so is limited, so it doesn't overgrow in the body, Geisbert said.

The Canadian vaccine, licensed to the Iowa company NewLink Genetics Corp., uses the same live virus as Profectus' candidate, a pathogen found in livestock called vesicular stomatitis virus.

Scientists have found vehicles for inciting an immune response that guards against Ebola in animals — mainly viruses that have been modified so the body recognizes them as Ebola but that don't cause sickness in humans. Several projects had shown safety and efficacy in animals, but were slow to advance into human trials.

University of Maryland medical researchers are testing a vaccine developed at the National Institute of Allergy and Infectious Diseases (where Dr. Fauci is out of, one may have seen him talking about "no worries, nothing to see here" with respect to the US being able to contain, without a large outbreak, Ebola on US shores), which is part of the National Institutes of Health.

The NIH vaccine uses a chimpanzee cold virus that carries an Ebola protein.

The viruses are genetically altered so they cannot reproduce, but the immune system nonetheless produces antibodies to counteract them. (that would be considered a "dead" virus vaccine verses the "live or weakened" virus methods).

There has been a question with vaccine makers, what is better, a continual "low grade infection", where the body will continually produce antibodies, thereby keeping the target virus in-check, or will a dose of "viral proteins (without a viral reproduction mechanism) be sufficient.. So possibly it really isn't about the "money" that could be made from continual "booster" or new variant (mutations of the earlier virus), but a matter of what works best to induce and maintain a sufficiently "high degree of anti-body activity" when the actual "full strength" target virus infection is contracted in the "wild" (real world)..

What "other" effects happen with a particular high level of antibody activity in the human? That is a discussion for the anti-vaccine threads

References:

http://oxfordmedicine.com/view/10.10...28-chapter-031

Amongst the most recent promising vaccines under development are a number of recombinant based systems. The most noticeable those based vesicular stomatitis virus (VSV) that expresses a single filovirus glycoprotein (GP) in place of the VSV glycoprotein.

A single dose vaccine has proved capable of protecting non-human primates against Sudan ebolavirus (SEBOV), Zaire ebolavirus (ZEBOV), Cote d’Ivoire ebolavirus (CIEBOV), and Marburgvirus (MARV) (Feldmann H et al. 2007; Geisbert et al. 2009).

Recently, a two-injection filovirus vaccine regime (challenge/booster) based on an adenovirus vector expressing multiple antigens from five different filoviruses, (ZEBOV NP, ZEBOV GP, SEBOV GP, MARV Ci67 strain GP, MARV Ravn strain GP, MARV Musoke strain NP, MARV Musoke strain GP), proved successful (Pratt et al. 2010).

All animals in these studies survived the initial filovirus challenge with a different strain or species of filovirus. However, there are a number of significant safety challenges in humans; particularly those with an altered immune status are yet to be overcome.

[Hervé]

Ebola Outbreak Was Quickly Contained in Congo: How?

by Bahar Gholipour, Staff Writer | October 15, 2014 05:40pm ET

This digitally-colorized scanning electron micrograph (SEM) shows Ebola virus particles budding from the surface of a cell. Credit: CDC/ NIAID

Aside from the three nations in West Africa that are struggling with the Ebola outbreak, another outbreak of the virus occurred in Central Africa and was quickly contained. Now, new studies confirm that the two outbreaks were unrelated, and offer explanations why one was contained, while the other spiraled out of control.

The Ebola outbreak in the Democratic Republic of the Congo (DRC) began July 26 and was the seventh outbreak in this region since the discovery of the virus in 1976. The first patient was a pregnant woman from Ikanamongo Village who likely contracted the virus when she butchered a bush animal. She died Aug. 11. About 70 more people also became ill and more than 40 died by October, but the outbreak seems to have been tapering off since.

In contrast, the Ebola outbreak in West Africa has affected at least 8,400 people and killed more than 4,000 people since it began in Guinea in early 2014 and spread to the neighboring countries of Liberia and Sierra Leone.

In one new study, published online today (Oct.15) in the New England Journal of Medicine, researchers performed genetic sequencing on virus samples taken from patients in Congo.

They found that the virus in the Congo outbreak is 99.2 percent similar to the Ebola virus that caused an outbreak in Congo in 1995, but is less similar (96.8 percent) to the virus currently circulating in West Africa.

The genetic findings, together with the geographic separation of the two outbreaks, make it clear that the outbreak in the DRC is an independent event with no connection to the epidemic in West Africa, the researchers said. [2014 Ebola Outbreak: Full Coverage of the Viral Epidemic]

Moreover, the newest outbreak in Congo will probably follow a similar course as other Ebola outbreaks in this region: Central African outbreaks in the past have typically had a low number of people affected, and have been brought under control within two to three months, the researchers said.

It is not clear exactly why outbreaks in Congo are easier to manage than the epidemic in West Africa, but experts have pointed to some differences between the two regions.

After experiencing six Ebola outbreaks in less than 40 years, Congo is well prepared, and the country's response to outbreaks is quicker and more effective than it might be elsewhere. "The time that it takes to respond to news of an outbreak has been shortened over the years," the researchers wrote.

In contrast, the three worst-hit countries in the West African Ebola outbreak had never encountered this virus.

Moreover, Congo outbreaks tend happen in isolated, forested areas. But in Guinea, Liberia and Sierra Leone, villages, towns and capital cities are well connected to each other via extensive networks of footpaths, dirt roads and paved highways, making it easier for the virus to spread between communities and across frequently traveled borders.

This is not the only time that two unrelated Ebola outbreaks happened simultaneously. In fact, when the virus first emerged in 1976, it caused two nearly simultaneous but unrelated outbreaks in Congo (which was then Zaire) and in Sudan.

[Sidney]

Quote from Bob
-----------------------------------------------------------------------------------------------
Get ready, here it comes Africa -

Being sent to WHO in Geneva, the first shipment goes out Monday.

VSV-EBOV is an experimental Ebola vaccine developed by researchers at the Public Health Agency of Canada’s National Microbiology Laboratory (NML).

This vaccine is considered "experimental". It is based on an animal virus called vesicular stomatitis virus (VSV) that is combined with a portion of the protein covering of the Ebola virus. When administered, it induces an immune response against the Ebola virus.

The VSV acts as the infectious "core" that is used to allow the virus proteins to be injected into the cells. The antibody response then rapidly goes after the resultant human viral infection, creating antibodies (and a genetic tag to those viral proteins). In theory, the safety question is to determine the dose level - how many infectious particles can be safely tolerated..

Being tolerated means, because of die-off of the infected human cells, how many can be safely cleared from the body and how many anti-bodies can be created.. Is that 20,000,000,000 (thats 20 billion) virus particles or 50 billion for instance.

Testing for appropriate dose level is happening at the US Walter Reed Army medical facility in Maryland USA, (the facility's Institute of Research).

Live virus verses weakened virus.. One of the factors to be determined is how often will a booster shot be required. For instance Yellow Fever vaccination requires an initial dose where in about 10-15 days "immune system protection" capability starts, and lasts for up to 10 years before they say a booster vaccination is required to keep more viral particles in the body so that antibody production continues. (a constant low grade war exists with antibody production going after a continual low grade "yellow fever")..

Canadian Statement - that they are performing a humanitarian effort to make available the vaccine products - they are helping the WHO fulfill their role in Africa overcome the Ebola virus outbreak..

Quote Canada's 'project' is NOT a "Bill Gates" virus vaccination campaign, but is instituted BY the CANADIAN GOVERNMENT. The other vaccine maker is based in BRITAIN, Glaxo-Smith-Kline. Gates has nothing to do with the EBOLA VACCINES being developed by CANADA. The US MILITARY ROLE is to obtain a vaccine for it's troops. USAMRIID and DTRA are two US government organizations who have contributed research and FUNDING for these other COUNTRIES.


(above from their website announcement at: http://www.phac-aspc.gc.ca/id-mi/vsv-ebov-fs-eng.php)

"The Government of Canada will be shipping 800 vials of its experimental Ebola vaccine to the World Health Organization (WHO) in Geneva, beginning with its first shipment on Monday, October 20, 2014. These shipments will fulfill the Government’s vaccine donation commitment to the ongoing Ebola outbreak in West Africa.

"The Public Health Agency of Canada is supplying the vaccine to the WHO in its role as the international coordinating body for the Ebola outbreak, so that the vaccine can be made available as an international resource. The WHO, in consultation with partners, including the health authorities from the affected countries, will guide and facilitate how the vaccine should be distributed and used.

"The remaining vials of the vaccine will be kept in Canada for further research and compassionate use as required."

-----------------------------------

VSV - understanding the nature of the viral engine that has been modified to contain Ebola proteins

Researchers expect different types of vaccines to have different effects on the immune system.

Because the vaccine being tested in Mali and Baltimore uses a weakened virus, it might be tolerated better but not last as long as vaccines that use live viruses, said Dr. Thomas Geisbert, a professor of microbiology and immunology at the University of Texas Medical Branch at Galveston who has studied Ebola for decades and helped develop the Profectus vaccine.

The trials are also testing the performance of varying dosage levels, ranging from 25 billion to 50 billion modified virus particles.

It is unclear whether some vaccine candidates could require rounds of booster shots to prolong immunity, or whether others might provide longer immunity but at greater risk of side effects.

Profectus' vaccine uses a live virus that has been genetically altered. It can still reproduce, but its ability to do so is limited, so it doesn't overgrow in the body, Geisbert said.

The Canadian vaccine, licensed to the Iowa company NewLink Genetics Corp., uses the same live virus as Profectus' candidate, a pathogen found in livestock called vesicular stomatitis virus.

Scientists have found vehicles for inciting an immune response that guards against Ebola in animals — mainly viruses that have been modified so the body recognizes them as Ebola but that don't cause sickness in humans. Several projects had shown safety and efficacy in animals, but were slow to advance into human trials.

University of Maryland medical researchers are testing a vaccine developed at the National Institute of Allergy and Infectious Diseases (where Dr. Fauci is out of, one may have seen him talking about "no worries, nothing to see here" with respect to the US being able to contain, without a large outbreak, Ebola on US shores), which is part of the National Institutes of Health.

The NIH vaccine uses a chimpanzee cold virus that carries an Ebola protein.

The viruses are genetically altered so they cannot reproduce, but the immune system nonetheless produces antibodies to counteract them. (that would be considered a "dead" virus vaccine verses the "live or weakened" virus methods).

There has been a question with vaccine makers, what is better, a continual "low grade infection", where the body will continually produce antibodies, thereby keeping the target virus in-check, or will a dose of "viral proteins (without a viral reproduction mechanism) be sufficient.. So possibly it really isn't about the "money" that could be made from continual "booster" or new variant (mutations of the earlier virus), but a matter of what works best to induce and maintain a sufficiently "high degree of anti-body activity" when the actual "full strength" target virus infection is contracted in the "wild" (real world)..

What "other" effects happen with a particular high level of antibody activity in the human? That is a discussion for the anti-vaccine threads

References:

http://oxfordmedicine.com/view/10.10...28-chapter-031

Quote Amongst the most recent promising vaccines under development are a number of recombinant based systems. The most noticeable those based vesicular stomatitis virus (VSV) that expresses a single filovirus glycoprotein (GP) in place of the VSV glycoprotein.

A single dose vaccine has proved capable of protecting non-human primates against Sudan ebolavirus (SEBOV), Zaire ebolavirus (ZEBOV), Cote d’Ivoire ebolavirus (CIEBOV), and Marburgvirus (MARV) (Feldmann H et al. 2007; Geisbert et al. 2009).

Recently, a two-injection filovirus vaccine regime (challenge/booster) based on an adenovirus vector expressing multiple antigens from five different filoviruses, (ZEBOV NP, ZEBOV GP, SEBOV GP, MARV Ci67 strain GP, MARV Ravn strain GP, MARV Musoke strain NP, MARV Musoke strain GP), proved successful (Pratt et al. 2010).

All animals in these studies survived the initial filovirus challenge with a different strain or species of filovirus. However, there are a number of significant safety challenges in humans; particularly those with an altered immune status are yet to be overcome.
-----------------------------------------------------------------------------------------------

Dear WHO, CDC and any other agency that this may concern.

NO THANKS!!!!!

[Hervé]

Troops or vaccines?

70-90% efficiency: Russia to send Ebola vaccine to W. Africa in 2 months

Published time: October 13, 2014 13:12
Edited time: October 15, 2014 08:38
Get short URL

Reuters / HO

In two months, Russia is planning to send a new experimental vaccine against Ebola to Africa, according to the country’s health minister. The efficiency of the drug, which is to be tested on the ground, is about 70-90 percent.

“Today we are discussing that we will have enough of Triazoverin vaccine in two months so that we can send them to our personnel in Guinea and test its efficiency in clinical conditions,” Health Minister Veronika Skvortsova said.

The vaccine has so far proved efficient against various hemorrhagic fevers, including the Marburg virus which is very similar to Ebola.

“The efficiency ranges between 70 and 90 percent and this is a very good indicator,” Skvortsova said.

Russia’ Virology Institute is preparing a whole group of drugs.

“They are basically genetically engineered drugs which can work both for disease treatment and prevention,” Skvortsova said.

Russian virologists, who have set up a laboratory in Guinea, are preparing to test the vaccine on primates.

“The vaccine we have produced is made from the attenuated strains [of the virus]. We now have enough to repeat the experiment on the primates and proceed to clinical trials.”

On Sunday, Skvortsova announced that Russian scientists are working on three potential Ebola vaccines which they expect to introduce as soon as in the next six months.

"We have created three vaccines,” she said in an interview with Rossiya-1 TV. “One vaccine is based on a strain of Ebola, and the other two have been created by means of genetic engineering.”

As of October 8, a total of 4,033 people had died from the Ebola outbreak, out of a total of 8,399 registered cases in seven countries, the World Health Organization (WHO) reported. For now, Liberia is the worst-hit with 4,076 cases and 2,316 deaths. It is followed by Sierra Leone, where there are 2,950 cases and 930 deaths.

According to the WHO, the fatality rate associated with Ebola averages roughly 50 percent, but has ranged from 25 percent to 90 percent in past outbreaks.



READ MORE: Scientists in Russia developing three Ebola vaccines

[Bob]

About the Ebola Zaire (modified) strains..

The variants, meaning mutations, in the EBOV-Z could lead to a method to allow the virus to become "weaker", so that it is able to infect MORE.. A virus with a high-burn rate kills so fast that the infection is stopped cause there are no more carriers alive.. The earlier erroneous 50% rate reported for the current outbreak in west Africa was WRONG due to statistical errors - the actual closer statistical death rate is more near 70% deaths.. Improved treatment reduces death rate no treatment and the rate is closer to 90% meaning a 10% at best natural immunity may exist in some people.

The warning about a vaccination that creates ONLY a 70-90% efficiency (in what protection?) means 10-30% of those infected with the unattenuated "full strength" in the wild strain, could do what Biopreparat (*) has been trying all along, come up with an un-stoppable bioweapon.. The remaining unprotected vectors will contain "ultra-strength" viruses.. perfect for the weaponization program.. This would be an alarming to release into Africa (or anywhere) an imperfect vaccine..

It is well known that bacteria can develop anti-biotic resistance... And luckily the anti-biotic arsenal is keeping up with "resistance"..

It was mentioned earlier in this thread, the AMPLIFICATION techniques rely on deliberately creating a PARTIAL MEASURE of killing off the pathogen, so that ONLY the stronger pathogens REMAIN.. THIS is the technique that Russian/Soviet block labs have used continually..

By doing what they are claiming they are doing in Africa right now, with this PARTIAL protection, means AMPLIFICATION IS the goal..

That is a bad move to let Russia let loose a PARTIAL protection virus system claimed to be a 'vaccine' - don't let that happen. Very bad.. NEVER EVER EVER ! release a partial effective product because of AMPLIFICATION which ALWAYS HAPPENS.. doing that.

* Biopreparat, "Биопрепарат" was the Soviet Union's major biological warfare agency from the 1970s onwards. It continues to be a vast, ostensibly civilian, network of secret laboratories, each of which focused on a different deadly bioagent. The modernized version VECTOR..

Pathogens that were successfully weaponized by the organization included (in order of completion):

• Smallpox
• Bubonic plague
• Anthrax
• Venezuelan equine encephalitis
• Tularemia
• Influenza
• Brucellosis
• Marburg virus (believed to be under development as of 1992)
• Ebola
• Machupo virus (believed to be under development as of 1992)
• Veepox (hybrid of Venezuelan equine encephalitis with smallpox)
• Ebolapox (hybrid of ebola with smallpox)

[Atlas]

From "Ebola Is Terrifying, But It Kills Far, Far Fewer People Than These Other Diseases", April 04 2014, by Connor Adams Sheets:

[...] Ebola is by no means among the most dire global health threats. It has killed far fewer people than many other diseases, and outbreaks generally strike a limited geographic area for a relatively short period of time before being eliminated.

That hasn't made Ebola, a hemorrhagic fever with no cure that kills gruesomely the majority of those it infects, any less feared.

Countless articles have been written about the supposed potential of a scourge of Ebola. Hit movies and best-selling books from “The Hot Zone” to “Outbreak” play on these fears, leaving people terrified that Ebola will kill millions in gruesome fashion.

But the truth is that there are many far more common diseases that have claimed hundreds of times as many lives as Ebola, and the chance that that will change anytime soon is highly unlikely, according to leading experts.

In comparison, another hemorrhagic fever called Lassa fever is “endemic in parts of West Africa including Sierra Leone, Liberia, Guinea and Nigeria,” where it infects between 300,000 and 500,000 people and kills about 5,000 each year, according to the Centers for Disease Control and Prevention. [...]

Dr. Ben Neuman, a virologist at the University of Reading, said. “If this virus was able to spread between people more easily than it currently does, it would have the potential to be more deadly than the black plague. But currently it is not.”

Ebola victims have a 25 to 90 percent chance of dying from the disease, but they have a limited chance of getting it in the first place, experts like Jonathan Ball, a professor of molecular virology at the University of Nottingham, say. “It’s worth remembering that this isn’t the most infectious virus,” Ball said. [...]

“If you look at the total number of cases that have occurred over that period since 1976, it’s somewhere around 2,200 cases,” Dr. Anthony S. Fauci, director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health, said. “Relatively speaking that’s a small number, of those about 1,500 have died to give it a 60 percent total mortality.”

But the enduring popular mythology that Ebola will take over the world like a zombie apocalypse does serve a purpose, as it generates media attention that helps efforts to contain outbreaks, according to Fauci.

“The publicity that’s associated with this is a good thing even though it’s scaring some people, because it makes people aware,” he said.

Source: http://www.ibtimes.com/ebola-terrify...seases-1567266

[Bob]

The use of unrelated statistics is useless IMHO.

There are treatments for other diseases, there is no treatment for Ebola or any other Filovirus. To repeatedly bring up other diseases, although tragic that those diseases exist, in any attempt to dissuade people from paying attention to develop a treatment for the filovirus.. continues to try to get people to look the other way.. won't happen.

The bug is out of the bag, there is no treatment. Partial measures of treatment can result in a hyper-strength bug, or a hyper-attenuated bug that can lead to a chronic state..

Don't deal with it or try to dissuade researchers from coming up with a complete solution, or 100% eradication, would open up disaster scenarios..

Let it be solved, not played down.

[Hervé]

Here is a quite comprehensive and documented article summarizing many angles to that potential plague:

EBOLA VIRUS EPIDEMIC: Planned In Advance; Release Of Aerosolized Virus And Deaths Would Frighten Americans To Demand Use Of Unproven Vaccines And Drugs

By Bill Sardi October 16, 2014

There is no ethical way to conduct a study of anti-Ebola virus vaccines and drugs in humans. You can’t intentionally inject individuals with a deadly virus and then give an inactive placebo pill to half of those who agree to participate as they do in most controlled human clinical studies. [Guardian UK Oct 10, 2014] An article published in Scientific American asked: “How do you test a human Ebola vaccine that works?” The answer: “You don’t.” [Scientific American Sept 17, 2004]

But what if the Ebola virus is spreading rapidly and killing hundreds or even thousands? The public would likely demand public health officials do something even if available vaccines and drugs are still unproven.

A manufactured outbreak of Ebola would force the issue. Something would have to be done. The public outcry for a cure would be deafening.

Was the unfolding Ebola epidemic contrived?
In a revealing report entitled “Ebola is in America – And, Finally, Within Range Of Big Pharma,” the London-based Guardian newspaper tells how the battle against Ebola was pre-planned. [Guardian UK Oct 4, 2014]

It appears an effort to drum up an Ebola virus crisis emanated from publication of a list of neglected diseases by the World Health Organization in 2012. With the publication of that list, 13 pharmaceutical companies teamed up with the World Health Organization and the Gates Foundation to control or eradicate ten diseases like tuberculosis, river blindness, sleeping sickness and Ebola.

The End Neglected Tropical Diseases Act [US Govt. Printing Office] introduced in Congress this year calls for the US to expand its disease-fighting activities to address international tropical diseases.

Investment houses are paying attention. “Ebola could be the issue that sends the whole thing snowballing. You are going to get more industry engagement. The signs were already positive after the London Declaration on neglected tropic diseases in 2012,” said a Deutsche Bank analyst. Commercial interests, not disease, are the driving force behind this epidemic.

That analyst also said: “To the extent that these diseases are starting to appear in the US, this will put the issue much more firmly on US companies’ radar.” Is this why the arrival of a single case of Ebola involving an airline traveler to the US is getting so much attention?

Once US citizens lives are threatened this will justify use of US funds to develop drugs and vaccines that poor countries can’t afford and also pawn the cost of human studies on the American public rather than pharmaceutical or vaccine makers. This will save billions of research and development dollars for the vaccine and drug companies.

And apparently both sides will profit. It is difficult to fathom that agencies purported to promote public health hold patents on varieties of deadly viruses like Ebola. [US Patent publication number US20120251502A1] One begins to wonder what business these public agencies are in – profiteering or health?

So the unprecedented Ebola virus outbreak occurs right on time, based upon questionable diagnostic tests to count up the numbers needed to gain world attention.

An article in Forbes Magazine says the Ebola epidemic has silenced critics of Big Pharma, especially “innovator” drug companies that have been criticized for using patents to produce over-priced drugs beyond the affordability of many countries with exotic tropical diseases.

Now, says the Forbes article, “with the tragic outbreak and ominous spread of the Ebola virus, the whole world seems to be knocking at the drug companies’ doors hoping they will devise some way to prevent or cure Ebola.” [Forbes.com Sept 11, 2014] But has the whole Ebola epidemic been contrived?

The next step is to involve the American public in the drama. [Guardian UK Oct 4, 2014] It’s beginning to sound more and more like the Ebola epidemic was pre-arranged.

Research into tropical diseases is chronically neglected, but the horror of it is the modern effort to quell this epidemic may be worse than the disease itself.

Is Ebola an aerosol weapon?
While public health authorities are saying only direct contact with the virus via body fluids serve as a vector to transmit Ebola from person to person, animal studies in the laboratory say otherwise. A published report says: “At the very least, the potential exists for aerosol transmission, given that virus is detected in bodily secretions, the pulmonary alveolar interstitial cells, and within lung spaces.” [Viruses Oct 15, 2012]
Unsurprisingly, Ebola virus and the whole class of filoviruses which includes the Marburg virus are characterized as potential bioweapons making the list of the CDC’s Category-A Bioterrorism Agents.

Ebola is described as being “relatively stable in aerosols” and can remain present on surfaces for extended periods of time. Tests were performed on monkeys to show that aerosolized Ebola, especially under low temperature and humid conditions, can result in increased body temperatures (a fever) beginning 4-5 days following initial exposure. This shocking report shows that infectious disease experts have already pre-tested Ebola as a bioweapon – and here is the key part of the report – “as a foundation for testing vaccines and therapeutics.”

The tests were conducted in 2012 by investigators at the US Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland [Viruses Oct 15, 2012] the very same bioweapons center where an engineered anthrax bacterium was genetically traced back to in the crisis following the 9-11 terrorist attacks. A similar test was performed by scientists at the same military bioweapons center in 1995. [International Journal Experimental Pathology Aug 1995]

It appears the heightened outbreak of Ebola in Central Africa actually emanated from cutbacks in public health funds directed toward control of the disease, not from the disease mutating into a more virulent form. [British Medical Journal Oct 2, 2014; Nature Oct 1, 2014] Was this pre-planned?

A shortage of doctors in regions of Central Africa has also been blamed on the spread of Ebola. [ZeroHedge.com]

Interestingly, two drug/vaccine makers developing therapeutic agents against the Ebola virus receive funding, not from the Centers For Disease Control, not from the National Institutes of Health, not from the World Health Organization, but from the US Department of Defense which has pre-tested Ebola in the animal lab as a terrorist bioweapon, not as a preventive vaccine. [CDC Aug 29, 2014]

Professor exposes the plot
In an outspoken article published in The Liberian Observer by Dr. Cyril Broderick, a former professor of plant pathology at the University of Liberia’s College of Agriculture, the pharmaceutical industry and the US Department of Defense are fingered as conspirators in a plot to intentionally spread Ebola to provoke public demand to use unproven vaccines and drug as rescue remedies.

Professor Broderick notes reports that the US Department of Defense funded Ebola trials on humans just prior to the Ebola outbreak in Guinea and Sierra Leone. In his letter addressed to all “world citizens,” Professor Broderick pleads for everyone to “please stand up to stop Ebola testing and the spread of this dastardly disease.” [Liberian Observer Sept 9, 2014]

Malnutrition as another cause
As millions of people around the world die of preventable infectious disease due to malnutrition (PLoS Medicine May 2007] public health authorities now focus their efforts on a single transmissible disease that kills an average about 40 people a year – the Ebola virus.

Stop the world – for Ebola
Inflating the priority of their own interests, over 40 public health officials and infectious disease specialists have written an open letter to European governments, locked up in a financial crisis of their own, to stop everything and “urge governments to mobilize all possible resources” in the control of “this horrific epidemic.” [The Lancet Oct 4, 2014]

Stopping Ebola has now become a worldwide priority even though it has been confined to Central and West Africa for decades. United Nations health officials describe it as “likely the greatest peacetime challenge the United Nations has ever faced.” [LA Times, Sept 18, 2014]

The discoverer of the Ebola virus, Peter Piot, says “In 1976 I discovered Ebola – now I fear an unimaginable tragedy.” [Guardian UK Oct 4, 2014]

For unexplained reasons this outbreak of the Ebola virus is said to be far greater than prior regional epidemics in 1976 (Sudan, Congo), 1995 (Congo), 2000 (Uganda) and 2007 (Uganda, Congo). [New York Times Oct 7, 2014] The current Ebola epidemic in Central and West Africa began in December of 2013.

Despite the fact that over the past 38 years since Ebola virus infection was first diagnosed less than 2000 have died from it over that time span, a report issued by National Public Radio says Ebola is currently growing by exponential numbers. [NPR Sept 18, 2014]

So why is Ebola virus being researched at all given its relatively low incidence? An article published in Canadian Medical Association Journal provides the answer: “Fears that Ebola could be turned into a bio-weapon. A spokesperson for one vaccine maker says: “Were there not a perceived need to protect against an Ebola outbreak being spread around the world as a bioterrorist weapon I don’t think anyone would be3 where we are now.” Another public health officer says: “If public health need was the absolute driver we would be absolutely nowhere because frankly not too many people were getting sick with Ebola.” [Canadian Medical Association Journal Oct 2, 2014]

Ironically, the only entity that has the technology and funding to develop a weaponized from of Ebola virus is the US biodefense conglomerate comprised of industry virologists and military bioweapons experts, not any rogue group of terrorists who are likely to kill themselves experimenting with such a deadly virus. The US has spent $79 billion on so-called biodefense since 2001. [Biosecurity Bioterrorism Sept 2013]

What happened to quarantine?
The lack of quarantine has been criticized widely. Why does it seem like public health officials are allowing travelers from Africa to travel without a health check? However, closing borders to quarantine large populations of people may not be practical says an article in Time Magazine. [Time Magazine Oct 6, 2014] Yet tried-and-true methods of walling-off Ebola via quarantine and confinement has worked at the Firestone rubber plantation in Liberia. [Wall Street Journal Oct 6, 2014] There’s no money in quarantine efforts.

Transmission of Infectious Disease During Air Travel
Getting back to the issue of airborne transmission: Tom Frieden, M.D., Director of Centers for Disease Control, said “at this point there is zero risk of transmission of Ebola on air flight. It does not spread from someone who doesn’t have fever or other symptoms.” [USA Today Oct 1, 2014] Thirty-eight years of Ebola virus says that statement is true. But maybe not if the deadly Ebola virus is being purposefully weaponized and instilled into an airplane cabin or airport by a terrorist. And maybe that terrorist isn’t wearing a towel on his head. The only organization with the knowledge of how to spread Ebola is the US Department of Defense.

The transmission of viruses during commercial air travel has been demonstrated to be a potential health threat. [The Lancet March 12, 2005]

Ebola can spread by aerosol transmission and also by direct contact with blood, mucus or other fluids from an infected person. Ebola can cause hemorrhagic fever. These viruses have long incubation periods, making infected passengers initially symptom-free and unaware that they are infected at the time of travel even though they can spread a disease by droplet transmission. These droplets are created by infected persons when they cough, sneeze or speak and the droplets are propelled up to 3 feet and deposited on a susceptible host’s eyes or mucous membranes. Other infectious diseases that can be transmitted during air flight: Tuberculosis, SARS, the common cold, influenza, meningococcal disease, measles, Salmonella, Cholera, smallpox, and others. So Ebola is not completely removed from the list of transmissible disease during air flight. It has been widely reported that 35 countries are one air flight away from Ebola-affected countries. [Quartz July 30, 2014]

A disturbing report describes a laboratory where Ebola-infected pigs were placed in a room with monkeys separated by a wire barrier from monkeys, yet the monkeys got sick even though there was no contact with blood, tears, sweat or other airborne vectors. [Scientific Reports Nov 2012]

Way back in 1999 in the Journal of Infectious Diseases researchers working for the Centers For Disease Control (CDC) reported on a scary outbreak of Ebola virus in the Congo. Some hospital visitors who did not come in contact with Ebola-infected patients came down with hemorrhagic fever. These researchers concluded that casual contacts might spawn future epidemics. [Journal Infectious Disease Feb 1999]
Another frightening report was published in 1992 showing that Ebola virus among lab animals (monkeys) spread to other animals despite discontinuation of all direct contact with other animals and handlers of animals developed antibodies to the virus, meaning it had spread to humans! [Lab Animal Science April 1992] This suggests the virus can escape from the animal lab to humans though it also suggests it did not emanate into full-blown hemorrhagic disease in animal handlers in a well-fed population (Virginia, USA).

Ebola: the comparable risk
The viral infection is said to be incurable because there are no proven drugs or vaccines for it and it has a high mortality rate, over 50%. [World Health Organization Sept 2014] So the fear factor associated with Ebola outranks the pervasiveness of other more prevalent diseases such as tuberculosis and malaria.

For comparison, a worldwide infectious disease threat like the flu has a mortality rate ranging from 9-20 per 100,000 in a well-nourished US population which includes pneumonia (data published 2013) which is a mortality rate of less than one-tenth of one percent. [Kaiser Family Foundation] That is why Ebola virus is so dreaded.

Americans have a 2000-times greater chance of developing malaria [CDC] and a 500-times greater risk from dying from tuberculosis [CDC 2013] than they do Ebola but a survey reveals 40% of Americans believe there will be a large outbreak of Ebola virus in the U.S. But that same news report says the fear of Ebola “is not even close to the actual reality” and that an individual’s chance of getting Ebola in the developed world are “virtually zero.” [NBC News Aug 26, 2014]

News media doubletalk
The news media actually dismisses itself for fomenting this unfounded fear. “Well, it might be our fault. Us, as in the news media” says a NBC report which quotes a risk communication expert to say the ongoing Ebola drama is “better than a zombie movie” with all of its mental pictures of blood pouring out of a hemorrhaging victim. The news media whips up the fear and then issues reports asking why is everyone so frightened. The news media is Big Pharma’s best friend.

Hey, in the news headline business it is well known “if it bleeds it leads.” Even on YouTube: “One drop of Ebola 12 million dead,” already viewed a half-million times online. [YouTube.com]

The news media revels in the hype knowing that fear of the spread of the disease attracts more readers and viewers which in turn further heightens the fear. The world is being drawn into a staged drama. Only this horror show is not make-believe like Halloween.

And now a CBS News report says there is a fear that some bio-terrorist is going to cross the southern border of the U.S. carrying a vial of Ebola virus [CBS News Oct 6, 2014] and no mention of the thousands of illegal immigrants crossing the border every day with tuberculosis, whooping cough and hepatitis and enrolling their kids in public schools. [American Association Physicians & Surgeons June 25, 2014]

The news media is Big Pharma’s best friend
Researchers further exacerbate these misplaced fears knowing research funds for human trials of vaccines and drugs will gain rapid approval and be fast-tracked. [The Economist Sept 13, 2014; New Scientist Sept 9, 2014]

The dead bodies piled high in Central Africa are for sure but most of these deaths are more likely the result of tuberculosis, malaria or Marburg virus.

Since the symptoms of Ebola and malaria are similar, it could be that many of the reported cases of Ebola are nothing more than malaria. In fact, among two patients placed in isolation in Washington DC-area hospitals, 1 had malaria.

As of October 1 the CDC had looked into 100 Ebola scares in 33 states and tested the blood of 15 possible Ebola patients and found only one patient who tested positive, the Liberian man who flew from Africa to Texas and was infected prior to his visit to the US. [WJLA-TV ABC News Affiliate Oct 4, 2014] He has now succumbed to the virus.

Misdiagnosis of Ebola
The confirmation of a diagnosis of Ebola is very specious.

The Centers For Disease Control publishes a list of diagnostic tests for Ebola. [CDC.gov] Definitive diagnosis rests on isolation of the virus by means of tissue culture in a lab dish or a sophisticated test known as reverse-transcription polymerase chain reaction (RT-PCR) assay.

However, isolation of Ebola virus in tissue culture is a high-risk procedure that can be performed safely only in a few high-containment laboratories throughout the world. [MedScape]

Furthermore, reporter Jon Rappoport in his excellent interview of the inventor of the PCR test, Kary Mullis, quotes Mullis to say: “Quantitative PCR is an oxymoron.” [Jon Rappoport] PCR testing produces questionable diagnoses.

Diagnosis of this viral disease is also confirmed by indirect blood markers (elevated interleukin-6 or tumor necrosis factor – IL-6 and TNF) that are commonly elevated in other diseases as well. Malaria also increases IL-6 and TNF. [Malaria Journal Aug 16, 2014]

Meanwhile a company in Japan is said to have developed a quicker Ebola test that within 30 minutes will diagnose this deadly virus. [IBTimes.com Sept 2, 2014]

Why has Ebola spread outside its geographical center?
In 38 years since the discovery of the Ebola virus in Central Africa this disease has never escaped its equatorial geographic zone but we are now led to believe it has killed more inside of a year than the prior 3+ decades and has escaped from Africa via airline travel to become a global health threat.

Ebola is now being called an inevitable transcontinental pandemic based upon two cases (a nurse who cared for an Ebola patient in Spain and an infected man who flew from Africa to Texas), as if this never happened before. In 38 years no one with Ebola virus in their bloodstream has ever traveled by air to a foreign land? News reports now say Ebola will spread from West Africa to France and beyond within days. [Daily Mail UK Oct 5, 2014] This is absurd.

Experimental vaccines proven long ago
Effective Ebola vaccines are not new. Experimental vaccines were shown in 1980, 2000 and 2001 to be effective against Ebola virus in monkeys. [Lancet Dec 13, 1980; Nature Nov 30, 2000; Bulletin World Health Organization Nov 5, 2001] But just how do you prove them safe and effective in human trials?

The problem is that vaccines are a little bit of the disease itself. They may cause vaccine-induced disease since they contain a weakened form of Ebola virus or segment of the virus. Vaccination with an unproven vaccine could result in a horrific outbreak of deadly Ebola, worse than the Ebola virus in a given population. That is the risk posed by these vaccines.

For example, if you live in Africa the threat of polio from the polio vaccine is now greater than the polio virus in circulation. [Morbidity & Mortality Weekly Report March 23, 2012; Weekly Epidemiological Record, WHO, Vol. 87, No. 38, 2012]

Oddly, over a decade ago an “extremely promising” experimental DNA Ebola virus vaccine was reportedly tested in humans using modified, inactivated genes. [New York Times Nov 19, 2003] This appears to be the same vaccine that was declared safe and effective in a human trial among healthy (non-infected) adults in 2006. [Clinical & Vaccine Immunology Nov 2006] The developer of that vaccine worked for the federal government’s Vaccine Research Center at the National Institutes of Health and a decade later accepted a position with a major pharmaceutical firm just about the same time the Big Pharma joined forces with the World Health Organization to tackle ten neglected tropical diseases. [ScienceMag.org Nov 15, 2012] This move reflects the revolving door between government and commercial enterprise.

Remember, efforts to quell the Ebola virus are to prevent just 40 deaths a year. It’s possible the vaccine could cause more disease and death than the natural disease. It’s more likely that efforts to improve nutrition and public hygiene would be more successful than mass vaccination. But don’t mention that to Wall Street that is banking on the stocks of vaccine makers to soar now. [The Motley Fool Oct 1, 2014]

Maybe you vaccinate and end up killing millions. Just like old drugs that have been found to work better than newer ones, maybe the newer vaccines are just versions of older serums being conjured up to develop patentable profits.

Natural immunity
Public health officials claim a person may have Ebola virus in their blood but it is only when it produces symptoms that it is contagious. [WebMD Oct 6, 2014] There is some truth to this as apparently some people have Ebola virus in their blood circulation but don’t develop symptoms.

In fact, since the year 2000 it has been reported that some people infected with the Ebola virus do not develop symptoms. [New York Times June 26, 2000] This means they have developed antibodies to ward off the disease or their immune system blunts the symptoms. So it cannot be said that humans do not develop natural immunity to Ebola.

A surprisingly high proportion of the population in the African country of Gabon appear to exhibit immunity from Ebola. There are healthy carriers of Ebola in Gabon. It is suspected that bats are a source of food for some Africans and may facilitate a low-dose exposure of Ebola to the immune system among people in Gabon. [Research Institute For Development Jan 2010] This means the human immune system is capable of warding off the disease even without a vaccine.

Nutraceuticals
It would be critically important for a successful trial of a drug or vaccine, forced onto the marketplace under the active threat of a pandemic, that no other alternatives be available. Plant-derived nutraceuticals have been proposed but remain untested. Nutraceuticals are inexpensive to produce and therefore can be used in developing countries. Natural remedies for Ebola have been mentioned. [Biotechnology Journal Oct 2013]

The dietary supplement industry jumps on the bandwagon to sell its nostrums saying its herbs and vitamins prevent or cure the disease (and they do) while public health authorities say natural remedies are unproven and to wait and let people needlessly die till drug and vaccine manufacturers come up with their own elixirs.

The Food & Drug Administration has been quick to warn consumers away from any natural remedies for Ebola. [FDA.gov] In response the dietary supplement industry cowers and responds to the FDA by saying it discourages use of dietary supplements for nutritional support in the face of Ebola virus when natural products are the only alternative in a health crisis such as this. [New Hope Oct 7, 2014]

There’s no vaccine. There’s no medicine. But good God, don’t dare try to use any natural remedies until we have some!

The illogic of the argument against natural remedies doesn’t hold. While it will be said that herbal remedies are unproven, what is being offered are existing or developmental drugs that will be used on an off-label or purely experimental basis. [PLoS One April 5, 2013; Wall St. Journal Oct 18, 2011]

Recognize, in a public health crisis there is no way public stockpiles of vaccines or antibiotics could possibly meet public demand. While public health authorities will likely warn the public away from natural remedies, they may be the only hope for the masses.

If there were a drug that worked to eradicate Ebola virus one should use it. However, there is no such drug or vaccine. It is a proven fact that malnutrition is linked to viral infections like Ebola. The typical seasonal shortage of food running from June through September in central Africa is a possible reason why the current Ebola virus outbreak has reached unprecedented levels. [Washington Post Sept 16, 2014]

In the midst of this Ebola outbreak public health authorities should be thinking “nutrition.” Instead they are thinking “vaccine deficiency,” “drug deficiency,” and how to raise the stock price of developmental drug and vaccine companies.

Ebola and vitamin C
It has been said that Ebola virus infection produces many of the same symptoms as scurvy, particularly internal hemorrhages. Most animals except fruit bats, guinea pigs and primate monkeys internally produce their own vitamin C. It may not be a coincidence that fruit bats, primate monkeys and humans are the primary at-risk species for Ebola virus.

Fruit bats are considered a vector for transmission of Ebola, which further points to depletion of vitamin C as a factor in acquired infection. Monkeys also have been found to harbor Ebola virus, again pointing to vitamin C deficiency as a virulence factor. [Developmental Biology May 14, 2013; Biochemical Genetics June 2013] In fact, with each human outbreak of Ebola virus there have been thousands of accompanying deaths of gorillas in the wild in Africa. [Science Dec 8, 2006]

Humans are in the same genetic predicament as these animals. Due to a gene mutation that universally affected all of humanity long ago in human history, humans no longer synthesize vitamin C. [Medical Hypotheses June 1979] Supplemental vitamin C may be a primary agent to reduce mortality among individuals with any tropical disease including Ebola.

The Orthomolecular News Service has issued a protocol for dosing of vitamin C for any viral infection. It calls for mega-dose vitamin C in the active treatment of viruses. [Orthomolecular News Service Aug 20, 2014]

Selenium depletion by Ebola virus
Selenium depletion by Ebola virus has been proposed as an explanation for the massive internal hemorrhaging associated with this infection. An overlooked fact is that selenium plays a role in blood clotting. As the Ebola virus replicates it requires more and more selenium proteins thus inducing depletion of selenium from the host. [Biological Trace Element Research Jan 1997; Journal Orthomolecular Medicine 1995] Depletion of selenium by Ebola virus induces both an incompetent immune response and rapidly mutated viruses. When selenium is provided to animals with virus infection mutation rates diminish. [Biological Trace Element Research Dec 2011] Zaire where Ebola virus first appeared has low soil levels of selenium. [Selenium Deficiency]

Estrogen cell receptor and Ebola
See comment in PubMed Commons below
Among the proposed drug targets to quell Ebola is the estrogen receptor. Two estrogen receptor targeted drugs have been proposed but there are natural molecules that block the estrogen receptor, namely from lignans from flaxseed and resveratrol from grapes. [Science Translational Medicine June 19, 2013; Molecular Nutrition Food Research March 2010; ELife April 25, 2014]

Cholesterol and Ebola
Two young children with a genetic cholesterol disorder (Niemann-Pick) where they are unable to produce sufficient amounts of cholesterol to supply cell surfaces have been declared resistant to contracting Ebola.

Department of Defense scientists actually took skin cells donated from kids who have this cholesterol disorder and tried to infect these cells with Ebola virus. The virus could not enter into the cells. [Science Daily Aug 24, 2011]

As background, viruses are not live and do not replicate on their own. Viruses require the genetic machinery of a living cell in order to multiply.

The young twin girls with the cholesterol disorder are also being treated with a common emulsifier used in drugs and dietary supplements that would theoretically block Ebola’s entry into living cells. Cyclodextrin has been shown to inhibit a respiratory virus. [AddiandCassi.com] Various news reports have mentioned cyclodextrin as a preventive agent against Ebola virus. [Wall Street Journal Oct 18, 2011]

Antioxidant combination
It has recently been reported that the combination of oral resveratrol, beta glucan and vitamin C work synergistically “as the strongest reducer of biological stress-related symptoms including IL-6.” [Molecules Sept 3, 2014] Vitamin D3 not only should be considered a primary anti-Ebola remedy because of its immune-boosting properties but also because it inhibits IL-6 and TNF, two blood markers of Ebola virus. [Age Aug 2014]

Natural anti-malarials
As many malaria-infected individuals are likely to be misdiagnosed as having Ebola, natural anti-malarials are of interest.

An interesting connection between the lost ability to self-heal from malaria and the amino acid taurine has been made. Mice deficient in taurine do not survive malaria. Taurine inhibits some of the common blood markers of Ebola virus including IL-6. [Infection Immunity April 2010]

In the animal lab vitamin D has been demonstrated to inhibit the occurrence of experimental cerebral malaria by suppressing the inflammatory response. [Journal Immunology Aug 1, 2014]

An antioxidant regimen consisting of vitamins C, E and glutathione has been shown to be helpful among patients with malaria. [Pakistan Journal Pharmaceutical Science April 2011]

Resveratrol
One of the indirect blood markers used help diagnose Ebola is interleukin-6 (IL-6). A strong IL-6 inhibitor is the red wine molecule resveratrol (res-vare-a-trol). Resveratrol also targets the estrogen receptor. [Scripps Institute] Resveratrol works synergistically with vitamin D to optimize the immune response. [Molecular Nutrition Food Research March 2014]

Garlic
A natural remedy that comes to mind that conquers all known viruses is garlic’s key molecule allicin. [Planta Medica Oct 1992]

Modern medicine is derelict in not putting allicin to a test against the Ebola virus. But Allicin has been successfully tested against malaria which most of the reported cases of Ebola are likely to be in reality.

The scientific literature shows that allicin from fresh-crushed garlic protects against acute malaria infection in laboratory animals. [Malaria Journal Aug 8, 2012] Allicin inhibits the parasite that causes malaria. [Bioorganic & Medicinal Chemistry Letters Sept 15, 2010] The primary anti-malarial activity of garlic emanates from allicin. [Antimicrobial Agents & Chemotherapy May 2006]

Be aware, standard garlic pills do not yield allicin due to destruction of the enzyme that activates it by stomach acid. Alkalinized garlic capsules reliably yield allicin.

Summary
The widely reported Ebola outbreak is overstated by health authorities and the news media. Malnutrition largely explains why Ebola virus has remained uniquely confined to central and western Africa. If Ebola escapes to other well-fed regions of the world it can only be sustained among those individuals who are immune compromised (smokers, diabetics, alcohol and drug abusers, immune suppressive drug users, infants and the very old).

If there is some sinister plot to intentionally expose the US population or any other human population for that matter to weaponized Ebola virus it will likely be foiled by good nutrition. Nutrition is to Big Pharma what a ring of garlic cloves is to Dracula.
The only entity that has advanced technology to spread Ebola is the bioweapons division of the US Department of Defense, not some towel-headed bio-terrorist. That is also where the anthrax bacterium was traced to in the aftermath of the 9-11 terrorist attacks.

Whether covert government operations exist to intentionally expose the American population to biological threats to put counter terrorist operations to the test will likely never be revealed. Whatever is going on, a giant mind control operation is currently underway as the current Ebola crisis is a massive fabrication on a worldwide scale.

In January of 2014 a US Depart of Defense-backed vaccine maker commenced a human trial of its Ebola vaccine among healthy adults. [Drugs.com Jan 2014] But it needs Ebola-infected individuals to prove its vaccine works in an epidemic. Why is another major vaccine maker taking the unprecedented step of starting mass production of a vaccine that has also just commenced testing in humans? [Vox.com Sept 18, 2014] All that’s needed for these investments to pay off is an “unexpected” outbreak of hemorrhagic Ebola virus infections to begin on US soil.

Will some overseas bioterrorist self-infect himself and jump on an airplane before a fever begins to develop and skip past airport health checks, then enter martyrdom by infecting others?

Or will the specific strain of Ebola virus be traced back to the US Army bioweapons lab at Ft. Detrick in Maryland like the weaponized anthrax bacterium that was spread through the US mail system and was cunningly directed at news sources (a tabloid paper in South Florida and NBC News in New York) as well as Congressional representatives and then blamed on an eccentric scientist in the laboratory there who had no motive to hush investigative sources who were delving into the events surrounding the 9-11 terrorist attacks?

According to surveys there is a growing body of Americans who believe that an Ebola attack is coming to America. The question is whether Americans will fall for the idea some lone terrorist inside some biological lab is capable of such a feat or whether a more sinister operation is underway by parties working on a larger scale. The current evidence points in the latter direction. As the late Dr. Stan Monteith frequently said: “America has the best enemies money can buy.” Can Americans face that truth? Maybe this time they can’t avoid it.

The Best of Bill Sardi

[avid]

However - all this new vaccine is hype-for-profit, and next-to-nothing on the efficacy of nano-silver (which was apparently blocked).
It would be more interesting to cut the BigPharma hype to the basics, and just let us see what nano-silver actually does.
Please let us do real open and honest trials with the non-profitmaking nano-silver, and any other plausible combatant of this virus. It's like watching economic-vultures circling over an evil brew. Brew your own, and share it in your locality. Eat loads of fresh fruit, and never have vaccinations.

[Atlas]

Posted by Bob (here)
Let it be solved, not played down.

I'd rather 'play down' Ebola and its 2,000 deaths per decade than just forget about HIV/AIDS and its 1 million deaths per year...

[Bob]

The bioweapons question - it's not stopped despite a treaty being signed.. The method to do "research" is to plaster it around "vaccine development" to protect the troops.. Not to protect the People..

The genetic splicing of monkey pox, or small pox, or any other pox into a filovirus, such as Marburg or Ebola IS being done. In my post 649 above, it is described as being used in certain vaccines, where the "pox" chosen has a relatively low chance of harming humans (but may be devastating to other primates). Post 653 explains some of the bioweapons, of which Ebola is one of them as is Marburg, both filoviri.

The idea behind allowing a bioweaponized version with a different component means increasing infectivity while allowing the main component "weapon" to remain relatively hidden within the infected carrier. One vector other than a POX being used is Equine Encephalitis (the Venezuelan strain is particularly excellent as a carrier) - there HAVE been recent outbreaks of that, WHY?

This noise on Ebola only punctuates the ultra-insidious bioweapons issues.

To add the noise to stop looking at Ebola is to force feed the public with ludicrous "burn-out" attempts to not pay attention to the MAIN THREAT which not only exists, it is being developed and refined. One thinks vaccines are insidious, so everyone goes to the fence to look through the hole and gets poked in the eye, and attention STAYS focused on the vaccines, the big pharma making $$ or WHATEVER distraction will sufficiently get MSM and the people to focus on it. Ebola is convenient right now because people are watching..

THE GOAL of the bioweapons military mindset is to do what is needed to distract, to look the other way, where the bioweapons are worked on. That is why they call their actions MITIGATION EFFORTS..

That is STEERING.. with known predictable outcome and apparent SOLUTION - (usually SEE, NOTHING TO SEE HERE... is the blather).

The list described in the post above, #653 (weapon) and #649 (countermeasure) IS what the major bioweapons developers and THREAT reduction Agencies across the world ARE doing.. That is where the attention needs focus on, Ebola is convenient now for the political button AND steering, and it is in-fact deadly. What has been pointed out are some of the ways it is being used, to bring more monitoring and more controls, and how it is being used POLITICALLY as a convenient platform and football.. It could easily be a resistant form of D68 affecting our children.. (but apparently there was not enough psychological warfare possible with the D68...)

The solution has been and AGAIN, pointing this out when it has been told that there are about a handful of simple pills which are 100% effective anti-virals, there is no need for vaccines, nor any other "treatment".. These same anti-virals cure HIV and Hepatitis, which work on filoviri - Taking such a pill when any symptoms appear means one could have in-vivo-vaccination, or whatever virus ails ya, your body will make its own needed antibodies, just as if you were naturally immune.. (that is what naturally immune means by the way, you developed your own anti-bodies through some form of earlier infection)....


And again that gets buried with useless statistical data.. interesting eh?



Lets keep the silver discussion to the silver thread

Reference to EEV -
http://emedicine.medscape.com/article/233913-overview - Venezuelan equine encephalitis

A 1995 outbreak of Venezuelan equine encephalitis in Colombia and Venezuela affected an estimated 75,000 humans; 3000 people developed neurologic complications, and 300 fatalities occurred. Of the estimated 50,000 equines infected, 8% died of the disease. This was the first major epidemic of Venezuelan equine encephalitis in 22 years.

EEV is a PRIME CHOICE for gene splicing in a filovirus PAYLOAD.. That then ups the "ebola-filovirus" infection potential - MUTATION or GENE SPLICED WEAPON.

TO downplay BIOWEAPONS developments is not in the best interests of humanity.

[Roisin]

Akron Mayor Don Plusquellic wants to keep Ebola patients out of Summit County hospitals



AKRON, Ohio — Mayor Don Plusquellic said Friday he wants medical teams on standby to transport any Northeast Ohio residents who show symptoms of Ebola to specialty hospitals out of state.

Plusquellic's idea is at odds with Summit County Public Health Medical Director Dr. Margo Erme, who got into a heated discussion with Plusquellic on South High Street Friday before a scheduled appearance on CNN. Plusquellic canceled his planned appearance but spoke with the Northeast Ohio Media Group shortly after.

Plusquellic said he reached out to U.S. Rep. Tim Ryan about the plan. Michael Zetts, a spokesman for Ryan, said the congressman fully supports Plusquellic's plan and is pushing for more assistance in Northeast Ohio.

"CDC changed it's opinion on what it takes to contract the virus," Plusquellic told NEOMG. "If the CDC can't say 'Here's what you need to protect yourself, and it's an absolute,' then I really don't want anyone here involved with anyone that has Ebola. I know that's a crass statement to make, but if we can avoid it and it can go to a place with a better understanding of Ebola, then it's better off."

Erme said she believes the 16 Northeast Ohio residents who had contact with Ebola patient Amber Joy Vinson, who spent the weekend in the Akron are, are safe here and that area hospitals are prepared to treat anyone who show symptoms of Ebola.
http://www.cleveland.com/akron/index...ical_team.html
-----------------------------------------------------------------------------------

MORE THAN 100 MONITORED FOR EBOLA SYMPTOMS IN OHIO; OBAMA OPPOSES CUTTING OFF WEST AFRICA

More than 100 monitored for Ebola symptoms in Ohio

Health officials in Ohio are monitoring more than 100 people following the visit by a Dallas nurse who tested positive for Ebola shortly after returning to Texas from the Cleveland area.

Officials said Saturday that none of those being monitored are sick.

State officials previously said 16 people Amber Vinson had contact with were being monitored. Officials say the sharp increase is a result of the identification of airline passengers who flew with Vinson between Dallas and Cleveland and the identification of people who also visited the dress shop where her bridesmaids were trying on dresses.

Vinson's stepfather is quarantined in his home in the Akron suburb of Tallmadge. That is where Vinson stayed during her visit.

The stepfather is the only person in the state under such a restriction.

http://7online.com/health/more-than-...frica-/351170/